FTCM
VACQU

First Trust Capital Management’s Vector Acquisition Corporation Unit VACQU Stock Holding History

First Trust Capital Management’s Portfolio VACQU Stock Details VACQU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-293,705
Closed -$3.16M – 268
2020
Q4 		$3.16M Hold
293,705
– – 0.89% 25
2020
Q3 		$2.98M Buy
+293,705
New +$2.96M 0.8% 27

Other funds holding VACQU

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

First Trust Capital Management's VACQU Position: Q1 2021 in Review

First Trust Capital Management sold out of Vector Acquisition Corporation Unit (VACQU) in Q1 2021, closing a stake of 293,705 shares — an estimated $3.16M sold.

First Trust Capital Management first reported a position in VACQU in Q3 2020 and held it in 2 quarters. The position peaked at $3.16M in Q4 2020. 8 funds tracked by Wall St. Rank hold VACQU as of Q1 2021.

  • First Trust Capital Management reported no remaining Vector Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
  • First Trust Capital Management sold 293,705 Vector Acquisition Corporation Unit shares in Q1 2021, an estimated $3.16M.
  • First Trust Capital Management first reported a position in Vector Acquisition Corporation Unit in Q3 2020 and held it in 2 quarters.
  • First Trust Capital Management's Vector Acquisition Corporation Unit position peaked at $3.16M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Vector Acquisition Corporation Unit as of Q1 2021.

Based on First Trust Capital Management's 13F filing for Q1 2021, filed 17 May 2021.